Specifically , the levosimendan and placebo group exhibited significantly different changes over time in GFR ( P = @ ) , renal blood flow ( P = @ ) , and renal artery diameter ( P = @ ) , with ensuing improvements in serum levels of BUN ( P = @ ) , creatinine ( P = @ ) , and cystatin C ( P = @ ) .